We are live on ! Find out more
WWB

Windward Bio Group

27.99 USD
-0.51
1.79%
At close Updated Nov 16, 11:25 AM EST
1 day
-1.79%
5 days
52.53%
1 month
-1.79%
3 months
-1.79%
6 months
-1.79%
Year to date
-1.79%
1 year
-1.79%
5 years
-1.79%
10 years
-1.79%
 

About: Windward Bio Group AG is a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, COPD, and atopic dermatitis. Its flagship program is WIN378, a potentially novel, long-acting, anti-TSLP monoclonal antibody. The pipeline also includes WIN027, a clinical-stage, long-acting anti-TSLPxIL-13 bi-specific, which has therapeutic application across immunological diseases.

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 0%
Negative 0%

We haven’t received any recent news articles for WWB

Price charts implemented using Lightweight Charts™